SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
AMLN (DIABETES DRUGS)
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
2173 62 0 AMLN
Emcee:  eric siegel Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2148The Lancet, Early Online Publication, 23 October 2009doi:10.1016/S0140-6736(09)6nigel bates-10/23/2009
2147news just hitting that the sanofi and novo concerns have put a fire under amln. scaram(o)uche-6/26/2009
2146uh..... hmmmmm........ anybody have a clue? rumor of the day.......scaram(o)uche-6/26/2009
2145Eastbourne Comments on Election of Directors at Amylin Annual Meeting of SharehoBiotech Jim-5/27/2009
2144Eastbourne Capital Files Presentation Outlining the Case for Change at Amylin PhJakeStraw-5/6/2009
21434:31PM Amylin Pharms announces a new sales approach to better target the diabetekenhott-5/4/2009
2142=DJ DEALWATCH: Lilly Can't Afford To Double Down With Amylin (This articrkrw-5/1/2009
2141Exenatide Once Weekly Provided Superior Glucose Control With Weight Loss Comparescaram(o)uche-3/31/2009
2140BJ et al: This is an almost free shot for AMLN. The milestone payments were reneDewDiligence_on_SI-2/6/2009
21391%, so you mean there's a chance? :)rkrw12/6/2009
2138Some of the companies like MRK may have balked on the lack of sufficient efficacBiotech Jim22/6/2009
2137Good question.DewDiligence_on_SI-2/3/2009
2136Then why AMLN keeps throw their precious cash away?RealMuLan-2/3/2009
2135This news is less than it seems, IMO. MRNA (f.k.a. Nastech) has never been able DewDiligence_on_SI-2/3/2009
2134AMLN is paying a small drug company to work on intranasal delivery of exenatide RealMuLan-2/3/2009
2133Byetta sales have dropped. <b>Amylin Q4 loss widens on charges, falling Bidos-1/28/2009
2132Press Release Source: Eli Lilly and Company Plans for Exenatide Once Weekly NDAkenhott-12/11/2008
2131Another GLP-1 agonist, not as potent as LAR but still a competitor: <b>Coidos-12/4/2008
2130Amylin Builds on the Success of Byetta Minor Label Changes and Approval of Once RealMuLan-11/16/2008
2129Institution dumping investorvillage.comRealMuLan-11/14/2008
2128Nope, one is enough<g> Here is azard Capital Markets on AMLN medadnews.comRealMuLan111/13/2008
2127welcome abroad! u rnt alone in biotech investments. Be patient tho! AMLN looksmlkr-11/13/2008
2126Very high, about $20. Although I did make some decent money on trading it beforeRealMuLan111/13/2008
2125RealMuLan thnx. good info..keep us posted! what is your average? GLmlkr-11/12/2008
2124One reason for AMLN going down so much is Marsico Capital Mgmt dumped 15.xx millRealMuLan111/10/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News